ANTICANCER PLANT PRINCIPLES
抗癌植物原理
基本信息
- 批准号:3165254
- 负责人:
- 金额:$ 15.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-04-01 至 1989-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The major objectives of this work is to isolate, purify and determine the
structure of the anticancer compounds present in Catharanthus roseus,
Catharanthus trichophyllus, Rhazya stricta, and Gnidia kraussiana.
Although Catharanthus roseus is a well established source of antitumor
agents of the dimeric indole alkaloid class, several highly active
fractions remain to be studied for their active constituents. The crude
alkaloid mixtures will be separated initially by pH gradient techniques and
subsequently by column chroamtography; monitoring each step with an
appropriate biological assay technique. A number of active bisindole
alkaloids have been isolated and must be characterized. Isolated compounds
will be identified by their mp, mass, UV and IR spectra, optical rotation
CD and PMR and CMR spectra. Structure elucidation will be carried out by
interpretation of these data, chemical correlation with known compounds and
in particularly difficult cases by single crystal X-ray crystallography.
The alkaloid fraction of the closely related plant Catharanthus
trichophyllus also displays very good in vivo antitumor activity and it is
proposed to isolate additional in vivo active compounds from this fraction
by techniques similar to those described above for Catharanthus roseus.
The Asian plant Rhazya stricta has afforded some in vitro active compounds
but further isolation studies are needed on active fractions and some
structural studies are still required. Rhazya orientalis will be grown for
biological testing. Gnidia kraussiana has afforded a number of
exceptionally cytotoxic fractions which have been obtained and it is
proposed to isolate the compounds responsible for this activity. These are
suspected to be tigliane or daphnane esters.
这项工作的主要目标是分离、纯化和确定
长春花中抗癌化合物的结构,
长春花属、狭叶林蛙和格氏草属植物。
虽然长春花属植物是一种公认的抗肿瘤来源
二聚吲哚生物碱类的试剂,几种高活性的
各组分的活性成分仍有待研究。原始人
生物碱混合物最初将通过pH梯度技术和
随后通过柱层析法;使用
适宜的生物检测技术。几种活性双吲哚
生物碱已被分离出来,必须加以鉴定。分离出的化合物
将通过它们的熔点、质量、UV和IR光谱、旋光度来鉴定
CD、PMR和CMR光谱。将通过以下方式进行结构说明
对这些数据的解释,与已知化合物的化学关联以及
在特别困难的情况下,通过单晶X射线结晶学。
近缘植物长春花中的生物碱成分
毛霉菌在体内也表现出很好的抗肿瘤活性,它是
建议从该组分中分离出额外的体内活性化合物
采用与上述长春花属植物相似的技术。
亚洲植物龙须菜在体外提供了一些活性化合物。
但还需要对活性组份和一些
仍然需要进行结构研究。东方林蛙将被种植用于
生物测试。Krussiana已经提供了一些
已经获得的特殊的细胞毒性部分,它是
建议分离出对这种活性负责的化合物。这些是
怀疑是三七烷酯或瑞香烷酯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geoffrey A Cordell其他文献
Geoffrey A Cordell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geoffrey A Cordell', 18)}}的其他基金
NOVEL STRATEGIES FOR PLANT-DERIVED ANTICANCER AGENTS
植物源抗癌药物的新策略
- 批准号:
3549682 - 财政年份:1990
- 资助金额:
$ 15.1万 - 项目类别:
INSTRUMENTATION AT UNIVERSITY OF ILLINOIS-CHICAGO
伊利诺伊大学芝加哥分校仪器仪表
- 批准号:
3524623 - 财政年份:1987
- 资助金额:
$ 15.1万 - 项目类别:
MINORITY HIGH SCHOOL STUDENT RESEARCH APPRENTICE PROGRAM
少数民族高中生研究学徒计划
- 批准号:
3510299 - 财政年份:1985
- 资助金额:
$ 15.1万 - 项目类别:
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
- 批准号:
23H03142 - 财政年份:2023
- 资助金额:
$ 15.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
- 批准号:
10949343 - 财政年份:2023
- 资助金额:
$ 15.1万 - 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
- 批准号:
23H01983 - 财政年份:2023
- 资助金额:
$ 15.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
- 批准号:
10459074 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
- 批准号:
22K12384 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
- 批准号:
21H01577 - 财政年份:2021
- 资助金额:
$ 15.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
- 批准号:
571251-2022 - 财政年份:2021
- 资助金额:
$ 15.1万 - 项目类别:
Idea to Innovation














{{item.name}}会员




